ECOG-ACRIN EAA173

Primary Category:

Treatment Protocols

Disease Category:

Multiple Myeloma

Status:

New, Open

Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)

Eligible for screening study DCP 001

NCT#03937635